Sun Pharma

Syndicate content

BHEL, Sun Pharma top Sensex losers

sensex_pti_1.jpg

It was a tough week for Indian shares with the benchmark indexes bearing the brunt as the rupee tumbled to a fresh all-time low of 61.80 versus the dollar on Tuesday. Fears of the U.S. Federal Reserv

Indian drug firms okay with US law on enhanced inspection

ranbaxy_1.jpg.crop_display.jpg

The Indian generic drug industry is generally receptive to the proposed US law on medicine even though it seeks to enhance US-FDA inspection of the manufacturing facilities globally for a fee.

Indus

Sun Pharma gets favourable US Supreme Court verdict in patent case

drugs_1.jpg.crop_display.jpg

Sun Pharmaceutical Industries on Wednesday said the US Supreme Court has given a favourable verdict in its patent case against Novo Nordisk over generic Prandin tablets used for treating diabetes.

US

BSE to include Coal India, Sun Pharma in Sensex

The premier stock exchange BSE would include Coal India and Sun Pharma in the Sensex effective from August 8, 2011. The opening bell ceremony to include Coal India in the BSE Sensex will be held on Mo

Indian drug major Sun Pharma takes control of Israeli Taro

Indian drug maker Sun Pharma has bought a controlling stake in Israeli Taro Pharmaceuticals after settling a prolonged legal battle with promoters of the acquired firm.

Sun, along with its subsidiari

Sun wins case against Israeli firm

Sun Pharma, which was fighting a takeover battle with Israeli pharma major Taro, on Wednesday said that the Supreme Court of Israel has given the ruling in favour of the company. The Court has unanimo

Sun wins patent case against Eli Lily over cancer drug

New Delhi, July 29: Sun Pharma today claimed victory over Eli Lily and Co in a patent litigation over Gemzar, used in cancer treatment, with a US federal court ruling in its favour.

Eli Lily had cont

No Articles Found

No Articles Found

No Articles Found

I want to begin with a little story that was told to me by a leading executive at Aptech. He was exercising in a gym with a lot of younger people.

Shekhar Kapur’s Bandit Queen didn’t make the cut. Neither did Shaji Karun’s Piravi, which bagged 31 international awards.